vaccines
Blood Test From Stanford-led Team Could Predict Vaccine Durability
Bone marrow cells called megakaryocytes produce platelets with transcriptional programs that enhance antibody response times to several vaccines.
Personalis Nabs $50M Investment From Merck, Extends Collaboration with Moderna
The company extended its collaboration to further advance an investigational personalized vaccine therapy under development by Merck and Moderna.
Pneumococcus Evolution, Spread Profiled With Genome Sequences, Mobile Phone Data
By combining mobility and genomic data, researchers traced Streptococcus pneumoniae transmission in South Africa, and evaluated vaccine effects on fitness.
In a trial of 23 Lynch syndrome patients, those who received the vaccine and developed neoantigen-specific T cells had a higher chance of remaining disease-free over 10 years.
GenDx, OSE Immunotherapeutics Ink Deal to Develop NGS CDx for Epitope-Based Cancer Vaccine
Under the deal, GenDx will develop and validate a companion diagnostic test for high-resolution typing of HLA-A*02 based on its IVDR-registered NGS products.